The application of detecting serum miRNA206, 155 in hyperthyroidism relapse after relieving#br#
JIANG Yanfeng1, CHEN Anzhi2*, HU Liaoliao3, QI Xuelin4
2017, 37(7):
814-818.
doi:10.3969/j.issn.10073205.2017.07.017
Asbtract
(
439 )
PDF (653KB)
(
125
)
Related Articles |
Metrics
[Abstract] Objective〖HTSS〗〓To investigate the clinical application value of detecting serum microRNA206, 155 in predicting hyperthyroidism relapse after drug withdrawal.
〖HTH〗〖WTHZ〗Methods〖HTSS〗〓The expression levels of serum microRNA206,155 in 142 patients with hyperthyroidism were detected by technology(45 cases in the nontreatment group, 41 cases in the relapse group and 56 cases in the nonrelapse group) in detecting serum T3, T4 and TSH levels by the electrochemical luminescence technology. The inner diameter(diameter, D) and the maximum systolic blood flow velocity(peak systolic velocity, Vmax) of the superior thyroid artery(superior thyroid, STA) were examined by color Doppler ultrasonography.
〖HTH〗〖WTHZ〗Results〖HTSS〗〓In the relapse group and the nontreatment group, the levels of T4,T3, STAD and Vmax were higher than those in the nonrelapse group, respectively, but TSH were lower(P<005). The levels of T4, T3, TSH, STAD and Vmax between the relapse group and the nontreatment group were compared, but without statistically significant difference(P>005). The expression of miRNA206 was negatively correlated with the expression of miRNA155(r=-0.692, P<001). MiRNA206 expression was negatively correlated with T4, T3, STAD and Vmax(r=-0.562, -0.593, -0.537, -0.519, P<001) and positively correlated with TSH(r=0.622, P<001). The expression of miRNA155 was positively correlated with serum T4, T3, STAD and Vmax(r=0.530, 0.562, 0.553, 0.503, P<001), and negatively correlated with TSH(r=-0.689, P<001). The sensitivity and specificity of miRNA206 and miRNA155 in the diagnosis of hyperthyroidism at the best critical value were 93.2% and 90.7%, 91.6% and 97.2%, respectively.
〖HTH〗〖WTHZ〗Conclusion〖HTSS〗〓The detection of serum microRNA206, 155 can be used in prediction of hyperthyroidism relapse after discontinuation of medicine treating, and may be an useful warning markers and intervention targets for hyperthyroidism treating.